Sheesh, I don't know whether to laugh or cry.
Something stank about the dermatology revenues after the AGM, now I'm wondering if they deliberately overstated the revenue for FY22 to avoid breaching debt covenants, so they could restate it later after they had retired all the debt? This is slowly starting to add up...
Either way, investors bought shares based on the information disclosed for the FY22 results, so watch this space. What I want to see now is some serious on-market purchases by the BOD and skin in the game (once the blackout period has passed.)
- Forums
- ASX - By Stock
- MYX
- Ann: Mayne Pharma to restate US dermatology net revenue for FY22
MYX
mayne pharma group limited
Add to My Watchlist
2.78%
!
$5.25

Ann: Mayne Pharma to restate US dermatology net revenue for FY22, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.25 |
Change
-0.150(2.78%) |
Mkt cap ! $426.5M |
Open | High | Low | Value | Volume |
$5.35 | $5.41 | $5.19 | $1.239M | 231.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $5.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.36 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 5.170 |
1 | 2492 | 5.160 |
1 | 2100 | 5.150 |
2 | 10600 | 5.130 |
1 | 14000 | 5.090 |
Price($) | Vol. | No. |
---|---|---|
5.360 | 1000 | 1 |
5.410 | 73 | 1 |
5.450 | 25000 | 1 |
5.460 | 4440 | 1 |
5.490 | 182 | 1 |
Last trade - 16.11pm 25/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online